The study involved a retrospective evaluation of 321 patients at one Minnesota hospital. Patients either received TLIF, MIS-TLIF or OLLIF to treat degenerative disc disease, spondylolisthesis, spondylosis, herniation, stenosis or scoliosis.
Here are four insights:
1. Researchers found significantly decreased blood loss in the OLLIF group compared to the TLIF cohort.
2. The surgery time rose significantly as BMI increased for patients receiving TLIF or MIS-TLIF.
3. The study revealed a BMI one-point increase yielded longer surgery time and increased blood loss in the TLIF group.
4. Researchers found OLLIF to be the safest surgery at any BMI compared to TLIF or MIS-TLIF.
More articles on MIS:
MIS surgeon Dr. Phillip Kravetz joins Physician Partners of America: 5 insights
Spinal Elements launches Clutch interspinous process device: 3 insights
Virginia spine surgeon becomes 1st in region to perform laminectomy using joimax device: 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.